Parallex BioAssays and axiVEND Announce a Distribution Agreement for The Americas
axiVEND, a newly established value-added solution provider, announced that it has signed a distribution agreement with Parallex BioAssays, to distribute the SnapChip, aka Chip2Chip technology, a multiplex assay platform with no detection cross-reactivity problems, for North and South America markets. Orland, FLA. (PRWeb) July 31, 2019 — The SnapChip is a simple approach to multiplexing that... Read more